MultiplexDX International

📍 Rockville, United States🗓 Founded 2015👥 38 employees💰 Last funded Sep 2018
MultiplexDX is an international corporation established in 2015 consisting of two units: MultiplexDX Inc. located in Maryland US and MultiplexDX s.r.o. located in Slovakia. Our main goal is to eliminate cancer misdiagnosis by launching 98% accurate, quantitative and accessible diagnostic tests. We also operate a boutique oligohouse offering highly specialized custom oligonucleotides to the research community. Our mission: By transforming breast cancer treatment non-responders into responders and ensuring durable responses, we aim to drastically increase survival rates by at least 50%. Objectives of the company are: i) development of the technologies and the products for molecular diagnostic markets superior to currently available products; ii) core facility service using proprietary Multiplex TM technology iii) development of hi-tech 3D digital pathology services. Find out more about MultiplexDX on our official website and in social media: http://www.multiplexdx.com/ https://www.facebook.com/multiplexdx/ https://twitter.com/@multiplexdx http://bit.ly/MDXGooglePlus https://www.youtube.com/c/multiplexdx
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2015
Founded
Investor geography1 country
Slovak Republic
1
Frequently asked questions
Who invested in MultiplexDX International?
MultiplexDX International has 2 investors on record on gritt.io, 2 mid-stage.
When did MultiplexDX International last raise funding?
The most recent investment in MultiplexDX International recorded on gritt.io was in September 2018.
When was MultiplexDX International founded?
MultiplexDX International was founded in 2015.
What industry is MultiplexDX International in?
MultiplexDX International operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MultiplexDX International based?
MultiplexDX International is headquartered in Rockville, United States.